MEDICINOVA INC (MNOV:NASDAQ)
$1.42 -0.03 (-2.069%)
Analysed MEDICINOVA INC (MNOV:NASDAQ) News Sources
MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment
08-06-2026
yahoo.com
MediciNova Announces Patient Enrollment Milestone Achieved in SEANOBI Study Expanded-Access-Program Evaluating MN‑166 (ibudilast) in ALS patients
15-07-2026
yahoo.com
MediciNova to Participate in Two Investor Conferences in September
08-09-2026
yahoo.com
MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)
24-09-2026
yahoo.com
MediciNova Announces Topline Results from MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
28-09-2026
yahoo.com
MediciNova stock tumbles on mixed Phase 2 NAFLD trial data
28-09-2026
yahoo.com
MediciNova Shares Fall After Phase 2 Tipelukast Trial Misses Primary Endpoints
28-09-2026
advfn.com
MediciNova Drug Falls Short on Liver Fat Parameter, Stock Tumbles
28-09-2026
yahoo.com
MediciNova to Participate in the Maxim Growth Summit
06-10-2026
yahoo.com
MediciNova CEO Provides Shareholder Update
12-10-2026
yahoo.com
What is the current price of MEDICINOVA INC (MNOV:NASDAQ)?
The current price of MEDICINOVA INC (MNOV:NASDAQ) is $1.42.
MEDICINOVA INC (MNOV:NASDAQ) absolute price change since previous trading day?
The absolute price change of MEDICINOVA INC (MNOV:NASDAQ) since the previous trading day is $-0.03.
MEDICINOVA INC (MNOV:NASDAQ) percentage price change since previous trading day?
The percentage price change of MEDICINOVA INC (MNOV:NASDAQ) since the previous trading day is -2.069%.
What is the most recent average sentiment score for MEDICINOVA INC (MNOV:NASDAQ)?
The most recent average sentiment score for MEDICINOVA INC (MNOV:NASDAQ) is 80 out of 100.
What is the most recent average sentiment for MEDICINOVA INC (MNOV:NASDAQ)?
The most recent sentiment for MEDICINOVA INC (MNOV:NASDAQ) is .
SEC-8K** Filing Available For MEDICINOVA INC (MNOV:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.